Canada markets close in 48 minutes

China Regenerative Medicine International Limited (8158.HK)

HKSE - HKSE Delayed Price. Currency in HKD
Add to watchlist
0.185+0.003 (+1.65%)
At close: 03:18PM HKT
Currency in HKD

Valuation Measures4

Market Cap (intraday) 55.37M
Enterprise Value 102.23M
Trailing P/E 10.66
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)0.80
Price/Book (mrq)4.70
Enterprise Value/Revenue 1.47
Enterprise Value/EBITDA -0.96

Trading Information

Stock Price History

Beta (5Y Monthly) 1.94
52-Week Change 3-81.24%
S&P500 52-Week Change 322.38%
52 Week High 31.190
52 Week Low 30.172
50-Day Moving Average 30.299
200-Day Moving Average 30.548

Share Statistics

Avg Vol (3 month) 313.23k
Avg Vol (10 day) 39.84k
Shares Outstanding 5304.25M
Implied Shares Outstanding 6304.25M
Float 8107.13M
% Held by Insiders 162.95%
% Held by Institutions 15.18%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4Sept 24, 2002
Last Split Factor 21:10
Last Split Date 3Sept 06, 2023

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin -154.99%
Operating Margin (ttm)73.12%

Management Effectiveness

Return on Assets (ttm)-7.07%
Return on Equity (ttm)-186.15%

Income Statement

Revenue (ttm)69.49M
Revenue Per Share (ttm)0.24
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -25.94M
Net Income Avi to Common (ttm)-107.7M
Diluted EPS (ttm)-0.380
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)3.33M
Total Cash Per Share (mrq)0.01
Total Debt (mrq)50.19M
Total Debt/Equity (mrq)425.60%
Current Ratio (mrq)1.14
Book Value Per Share (mrq)0.04

Cash Flow Statement

Operating Cash Flow (ttm)N/A
Levered Free Cash Flow (ttm)N/A